University Hospital Schleswig-holstein

This study tests the drug tralokinumab in 30 adults with moderate-to-severe atopic dermatitis (eczema) that affects the genital area. The goal is to see if the treatment reduces itching and skin symptoms over 52 weeks. Participants receive the drug as part of their regular care, …

This study compares early treatment with mirikizumab (a biologic) to the standard approach with azathioprine in 300 adults newly diagnosed with moderate-to-severe ulcerative colitis. Participants are randomly assigned to receive either mirikizumab or azathioprine for 52 weeks. Th…

This study tests whether a new form of nicotinic acid (vitamin B3), designed to release in the lower gut, can help people with prediabetes return to normal blood sugar levels and avoid type 2 diabetes. About 390 adults with prediabetes will take either the drug or a placebo daily…

This study is screening 2,000 people aged 50 to 99 who do not have Parkinson's disease but may have early risk signs. Researchers will follow participants for five years to track changes in movement, thinking, and other symptoms. The goal is to better understand how Parkinson's d…

This study looks at why many people with Parkinson's disease crave sugary foods and whether eating fast-acting sugars improves their symptoms. Researchers will give 50 participants a sugar drink and a placebo on different days, measuring insulin, blood sugar, and movement. The go…